Skip to main content
. Author manuscript; available in PMC: 2013 Dec 10.
Published in final edited form as: J Neurosci Methods. 2011 Oct 17;203(2):10.1016/j.jneumeth.2011.10.009. doi: 10.1016/j.jneumeth.2011.10.009

Fig. 4.

Fig. 4

Suppression of orexin expression in the LH by vivo-morpholinos. (A) Quantification of cell counts for orexin in the LH at different time points following control (ctl) or antisense (AS) vivo-morpholinos (150 pmol each). Non-inj. indicates cell counts in a non-injected control. One-way ANOVA, (F (5, 37) = 3.76, p<0.01). * indicates p < 0.05 by Tukey post-hoc analysis. (B) Cell counts for MCH following treatment with orexin vivo-morpholinos. In both panels, N represents number of animals.